ResMed Work in process increased by 105.5% to $1.99M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 39.3%, from $3.28M to $1.99M. Over 4 years (FY 2021 to FY 2025), Work in process shows a downward trend with a -13.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.65M | $3.49M | $4.00M | $4.48M | $3.08M | $4.49M | $3.02M | $3.53M | $3.96M | $5.19M | $2.94M | $1.85M | $2.71M | $2.47M | $2.57M | $3.28M | $2.55M | $1.97M | $968.00K | $1.99M |
| QoQ Change | — | -24.8% | +14.4% | +12.1% | -31.3% | +46.0% | -32.9% | +17.1% | +12.1% | +31.2% | -43.3% | -37.3% | +47.0% | -9.1% | +4.1% | +27.7% | -22.2% | -22.9% | -50.7% | +105.5% |
| YoY Change | — | — | — | — | -33.8% | +28.5% | -24.6% | -21.2% | +28.6% | +15.6% | -2.4% | -47.7% | -31.4% | -52.5% | -12.7% | +77.7% | -6.0% | -20.3% | -62.3% | -39.3% |
| % of Inventories | 1.0% | 0.7% | 0.7% | 0.7% | 0.4% | 0.5% | 0.3% | 0.3% | 0.4% | 0.5% | 0.3% | 0.2% | 0.3% | 0.3% | 0.3% | 0.4% | 0.3% | 0.2% | 0.1% | 0.2% |
| Share Change | — | -0.3pp | -0.0pp | -0.0pp | -0.3pp | +0.1pp | -0.2pp | +0.0pp | +0.0pp | +0.1pp | -0.2pp | -0.1pp | +0.1pp | -0.1pp | +0.0pp | +0.1pp | -0.1pp | -0.1pp | -0.1pp | +0.1pp |